Literature DB >> 31133157

Risk Factors for Infectious Complications in Patients Undergoing Retrograde Intrarenal Surgery.

Demirhan Orsan Demir1, Omer Gokhan Doluoglu1, Yildiray Yildiz1, Selen Bozkurt2, Ali Ayyildiz1, Arif Demirbas1.   

Abstract

OBJECTIVE: To investigate the risk factors that may cause urinary tract infection (UTI) in patients applied with retrograde intrarenal surgery (RIRS). STUDY
DESIGN: An observational study. PLACE AND DURATION OF STUDY: Departments of Urology, Ankara Training and Research Hospital, Turkey, from September 2014 to April 2017.
METHODOLOGY: A retrospective examination was made of patients who underwent RIRS. The patients were separated into 2 groups as those with no UTI in the postoperative period (Group 1) and those with UTI (Group 2). The groups were compared in respect of age, stone size, operating time, presence of residual stone, and body mass index. Continuous independent variables were compared using the Student's t-test and in the comparison of categorical variables, the Chisquare test was used. A value of p<0.05 was accepted as statistically significant.
RESULTS: Group 1 comprised 169 patients with no UTI and Group 2, 20 patients with UTI. The mean operating time was 55.82 ±14.73 minutes in Group 1 and 75.5 ±23.9 minutes in Group 2 (p=0.002). In multivariate analysis, operating time was determined as an independent prognostic risk factor increasing the risk of infection (p=0.001). The cut-off value determined with ROC analysis was 61 minutes. When operating time exceeded 61 minutes, the infection risk was increased 11.1-fold (sensitivity 75%, specificity 76%, AUC 0.76).
CONCLUSION: Operating time in patients applied with RIRS was determined to be an independent prognostic risk factor for UTI risk in the postoperative period. In patients where surgery lasts more than 1 hour, particular attention should be paid in respect of infection risk.

Entities:  

Mesh:

Year:  2019        PMID: 31133157     DOI: 10.29271/jcpsp.2019.06.558

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  7 in total

1.  Risk factors for urinary infection after retrograde upper urinary lithotripsy: Implication for nursing.

Authors:  Chuan Peng; Zhaozhao Chen; Jun Xu
Journal:  Medicine (Baltimore)       Date:  2021-08-06       Impact factor: 1.817

2.  Does previous open or percutaneous renal stone surgery affect retrograde intrarenal surgery outcomes?

Authors:  Özer Güzel; Can Aykanat; Yılmaz Aslan; Ahmet Asfuroğlu; Melih Balcı; Altuğ Tuncel
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

3.  Factors affecting operative time during ureteroscopy and stone treatment and its effect on outcomes: retrospective results over 6.5 years.

Authors:  Lily Whitehurst; Amelia Pietropaolo; Robert Geraghty; Rena Kyriakides; Bhaskar K Somani
Journal:  Ther Adv Urol       Date:  2020-06-23

4.  Risk factors of febrile urinary tract infections following retrograde intrarenal surgery for renal stones.

Authors:  Dong Soo Kim; Koo Han Yoo; Seung Hyun Jeon; Sang Hyub Lee
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

Review 5.  Risk factors for infectious complications after retrograde intrarenal surgery - a systematic review and narrative synthesis.

Authors:  Bartosz Dybowski; Ewa Bres-Niewada; Marzena Rzeszutko; Aleksandra Tkaczyk; Barbara Woźniak; Marta Wójcik; Zuzanna Znajdek
Journal:  Cent European J Urol       Date:  2021-09-09

6.  Can the Stone Scoring Systems Be Used to Predict Infective Complications of Retrograde Intrarenal Surgery?

Authors:  Samet Senel; Cuneyt Ozden; Yilmaz Aslan; Yalcin Kizilkan; Cevdet Serkan Gokkaya; Binhan Kagan Aktas
Journal:  Med Princ Pract       Date:  2022-01-19       Impact factor: 2.132

7.  Risk factors of infectious complications after retrograde intrarenal surgery: a retrospective clinical analysis.

Authors:  Hua Zhang; Tao Jiang; Rui Gao; Qin Chen; Weiwen Chen; Changyi Liu; Houping Mao
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.